| Literature DB >> 31978345 |
M Zaeem Cader1, Rodrigo Pereira de Almeida Rodrigues1, James A West2, Gavin W Sewell1, Muhammad N Md-Ibrahim1, Stephanie Reikine3, Giuseppe Sirago1, Lukas W Unger1, Ana Belén Iglesias-Romero1, Katharina Ramshorn1, Lea-Maxie Haag1, Svetlana Saveljeva1, Jana-Fabienne Ebel4, Philip Rosenstiel4, Nicole C Kaneider1, James C Lee1, Trevor D Lawley5, Allan Bradley6, Gordon Dougan7, Yorgo Modis3, Julian L Griffin8, Arthur Kaser9.
Abstract
Mutations in FAMIN cause arthritis and inflammatory bowel disease in early childhood, and a common genetic variant increases the risk for Crohn's disease and leprosy. We developed an unbiased liquid chromatography-mass spectrometry screen for enzymatic activity of this orphan protein. We report that FAMIN phosphorolytically cleaves adenosine into adenine and ribose-1-phosphate. Such activity was considered absent from eukaryotic metabolism. FAMIN and its prokaryotic orthologs additionally have adenosine deaminase, purine nucleoside phosphorylase, and S-methyl-5'-thioadenosine phosphorylase activity, hence, combine activities of the namesake enzymes of central purine metabolism. FAMIN enables in macrophages a purine nucleotide cycle (PNC) between adenosine and inosine monophosphate and adenylosuccinate, which consumes aspartate and releases fumarate in a manner involving fatty acid oxidation and ATP-citrate lyase activity. This macrophage PNC synchronizes mitochondrial activity with glycolysis by balancing electron transfer to mitochondria, thereby supporting glycolytic activity and promoting oxidative phosphorylation and mitochondrial H+ and phosphate recycling.Entities:
Keywords: C13orf31; Crohn's disease; FAMIN; LACC1; Still's disease; immunometabolism; pH homeostasis; purine metabolism; purine nucleotide cycle; redox homeostasis
Mesh:
Substances:
Year: 2020 PMID: 31978345 PMCID: PMC6978800 DOI: 10.1016/j.cell.2019.12.017
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582